Literature DB >> 25435118

Brain tumors.

Murali Chintagumpala1, Amar Gajjar2.   

Abstract

The past 2 decades have witnessed a revolution in the management of childhood brain tumors, with the establishment of multidisciplinary teams and national and international consortiums that led to significant improvements in the outcomes of children with brain tumors. Unprecedented cooperation within the pediatric neuro-oncology community and sophisticated rapidly evolving technology have led to advances that are likely to revolutionize treatment strategies and improve outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaplastic astrocytoma; Diffuse intrinsic pontine glioma; Ependymoma; Glioblastoma; Medulloblastoma

Mesh：

Year:  2015        PMID： 25435118     DOI： 10.1016/j.pcl.2014.09.011

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  9 in total

Review 1.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

2.  Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.

Authors:  Yu-Long Lan; Xun Wang; Jia-Cheng Lou; Bin-Bin Ma; Jin-Shan Xing; Shuang Zou; Bo Zhang
Journal:  J Neurooncol       Date:  2017-12-26       Impact factor: 4.130

Review 3.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

4.  18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.

Authors:  Mark Muzi; Lanell M Peterson; Janet N O'Sullivan; James R Fink; Joseph G Rajendran; Lena J McLaughlin; John P Muzi; David A Mankoff; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-06-25       Impact factor: 10.057

5.  Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

Authors:  Rishi R Lulla; Stewart Goldman; Tohru Yamada; Craig W Beattie; Linda Bressler; Michael Pacini; Ian F Pollack; Paul Graham Fisher; Roger J Packer; Ira J Dunkel; Girish Dhall; Shengjie Wu; Arzu Onar; James M Boyett; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2016-03-28       Impact factor: 12.300

6.  Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.

Authors:  Cassie Kline; S John Liu; Sai Duriseti; Anuradha Banerjee; Theodore Nicolaides; Shannon Raber; Nalin Gupta; Daphne Haas-Kogan; Steve Braunstein; Sabine Mueller
Journal:  J Neurooncol       Date:  2018-09-11       Impact factor: 4.130

Review 7.  Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.

Authors:  Jamie Tisnado; Robert Young; Kyung K Peck; Sofia Haque
Journal:  J Child Neurol       Date:  2016-04-12       Impact factor: 1.987

8.  A prospective study of corpus callosum regional volumes and neurocognitive outcomes following cranial radiation for pediatric brain tumors.

Authors:  Arif Rashid; Ashwin N Ram; Wendy R Kates; Kristin J Redmond; Moody Wharam; E Mark Mahone; Alena Horska; Stephanie Terezakis
Journal:  Childs Nerv Syst       Date:  2017-04-28       Impact factor: 1.475

9.  Novel management of glioma by molecular therapies, a review article.

Authors:  Amin Alinezhad; Fatemeh Jafari
Journal:  Eur J Transl Myol       Date:  2019-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.